PE20040670A1 - Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida - Google Patents

Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida

Info

Publication number
PE20040670A1
PE20040670A1 PE2003001121A PE2003001121A PE20040670A1 PE 20040670 A1 PE20040670 A1 PE 20040670A1 PE 2003001121 A PE2003001121 A PE 2003001121A PE 2003001121 A PE2003001121 A PE 2003001121A PE 20040670 A1 PE20040670 A1 PE 20040670A1
Authority
PE
Peru
Prior art keywords
composition
isopropamide iodide
ambroxol
pharmaceutical compositions
compositions containing
Prior art date
Application number
PE2003001121A
Other languages
English (en)
Inventor
Nobuo Miyadai
Norimitsu Umehara
Minoru Okada
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20040670A1 publication Critical patent/PE20040670A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE COMO COMPUESTOS FARMACOLOGICAMENTE ACTIVOS UNA COMBINACION DE UNA CANTIDAD EXPECTORANTE EFECTIVA DE BROMHEXINA O AMBROXOL Y UNA CANTIDAD PARASIMPATICA (ANTICOLINERGICA) EFECTIVA DE YODURO DE ISOPROPAMIDA. UNA COMPOSICION PREFERIDA ES UNA SAL DE HIDROCLORURO DE AMBROXOL EN UNA CANTIDAD DE 5 A 90 MG CON 1 A 25 MG DE YODURO DE ISOPROPAMIDA, COMO DOSIFICACION DIARIA PARA ADULTOS. ESTA COMPOSICION PRESENTA UNA RELACION DE MEZCLA DE YODURO DE ISOPROPAMIDA A AMBROXOL EN UN INTERVALO DE 0,01 A 5 PARTES EN PESO. DICHA COMPOSICION PUEDE SER SOLIDA, SEMISOLIDA O LIQUIDA Y ADEMAS PUEDE COMPRENDER UNO O MAS COMPUESTOS ACTIVOS SELECCIONADOS DE ANTIPIRETICOS, ANALGESICOS, ANTIHISTAMINAS, ANTITUSIVOS, FARMACOS ESTIMULANTES, VITAMINAS, FARMACOS EN BRUTO, ANTIACIDOS Y PROTECTORES DE MUCOSA, ANTILOGISTICOS, ENZIMAS DE EXTENCION Y EXPECTORANTES. ESTA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE LOS DISTINTOS SINTOMAS CAUSADOS POR EL CATARRO COMUN
PE2003001121A 2002-11-08 2003-11-06 Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida PE20040670A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02024891A EP1417961A1 (en) 2002-11-08 2002-11-08 New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide

Publications (1)

Publication Number Publication Date
PE20040670A1 true PE20040670A1 (es) 2004-11-18

Family

ID=32103916

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003001121A PE20040670A1 (es) 2002-11-08 2003-11-06 Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida

Country Status (7)

Country Link
EP (1) EP1417961A1 (es)
JP (1) JP2006506407A (es)
AR (1) AR041999A1 (es)
AU (1) AU2003301802A1 (es)
PE (1) PE20040670A1 (es)
TW (1) TW200500061A (es)
WO (1) WO2004041263A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
JP4899304B2 (ja) * 2004-10-19 2012-03-21 大正製薬株式会社 塩酸アンブロキソール含有内服用固形製剤
JP2007291067A (ja) * 2006-03-29 2007-11-08 Daiichi Sankyo Healthcare Co Ltd 医薬組成物
JP2009001548A (ja) * 2007-05-21 2009-01-08 Daiichi Sankyo Healthcare Co Ltd トレハロースからなる気道杯細胞過形成抑制剤。
KR101915056B1 (ko) * 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
CN102670607A (zh) * 2012-05-28 2012-09-19 海南卫康制药(潜山)有限公司 复方盐酸氨溴索组合物及其制备方法
KR102447263B1 (ko) * 2014-05-23 2022-09-26 사노피-아벤티스 도이칠란트 게엠베하 암브록솔 하이드로클로라이드를 함유하는 기침 약물
JP7024248B2 (ja) * 2016-09-01 2022-02-24 大正製薬株式会社 固形製剤
WO2018182546A1 (en) 2017-03-27 2018-10-04 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray
AU660824B2 (en) * 1992-06-12 1995-07-06 Teijin Limited Pharmaceutical preparation for intra-airway administration
JPH08325142A (ja) * 1995-05-26 1996-12-10 Sumitomo Pharmaceut Co Ltd ヨウ化イソプロパミド含有製剤
JPH1045591A (ja) * 1996-05-22 1998-02-17 Taisho Pharmaceut Co Ltd 鎮咳剤
JPH1045577A (ja) * 1996-08-05 1998-02-17 Taisho Pharmaceut Co Ltd 風邪用咳止め薬
JPH1072349A (ja) * 1996-08-30 1998-03-17 Taisho Pharmaceut Co Ltd 鎮咳剤
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
JP2001233765A (ja) * 2000-02-24 2001-08-28 Ss Pharmaceut Co Ltd 感冒薬
JP2003081821A (ja) * 2001-09-12 2003-03-19 Taisho Pharmaceut Co Ltd 医薬組成物
JP4695326B2 (ja) * 2001-12-21 2011-06-08 第一三共ヘルスケア株式会社 鼻炎用医薬組成物

Also Published As

Publication number Publication date
TW200500061A (en) 2005-01-01
WO2004041263A1 (en) 2004-05-21
AU2003301802A1 (en) 2004-06-07
JP2006506407A (ja) 2006-02-23
AR041999A1 (es) 2005-06-08
EP1417961A1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
AR111572A2 (es) Formas farmacéuticas que contienen vardenafilo
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
BRPI0108380B8 (pt) fórmulas de opióides agonistas resistentes à adulteração, método para diminuir o abuso de um opióide agonista numa fórmula de dosagem oral, método de preparação de uma fórmula de dosagem oral e método de tratamento da dor
CO5261517A1 (es) Composiciones farmaceuticas analgesicas que contienen buprenorfina/naloxona, buprenorfina/naltrexona o buprenorfina/nalmefen en bajas dosis
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
PE20060485A1 (es) Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits
AR026916A1 (es) Combinaciones farmaceuticas y su uso en el tratamiento de desordenes gastrointestinales
BRPI0712976A2 (pt) uso de 2-aminotetralinas substituÍdas para a fabricaÇço de um medicamento para a prevenÇço, alÍvio e/ou tratamento de vÁrios tipos de dor
MA29744B1 (fr) Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree
PE20030824A1 (es) Formulacion superfina de formoterol
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
AR063782A1 (es) Parche y metodo transdermico para emesis
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
AR062775A1 (es) Composicion farmaceutica capaz de mejorar la actividad de glp -1 en un ser humano y su uso para preparar un medicamento
PE20040670A1 (es) Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida
PE20040973A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
BRPI0413693A (pt) composição farmacêutica para a prevenção e tratamento da viciação em um mamìfero
BR0210595A (pt) Regime de dosagem e composição farmacêutica para contracepção de emergência
AR040248A1 (es) Farmaco para el tratamiento de la vejiga hiperactiva
UY27759A1 (es) Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
BR0114100A (pt) Formulações de liberação controlada para administração oral
AR046036A1 (es) Composiciones de risedronato y metodos para su uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal